氨甲环酸对多发性创伤合并穿透性创伤性脑损伤大鼠模型的神经病理、脑电图及脑内纤维蛋白沉积的影响
本研究在Sprague-Dawley大鼠中建立单侧额叶穿透性弹道样脑损伤合并低氧血症和失血性休克模型,脑损伤后5分钟开始30分钟呼吸窘迫和30分钟失血,失血结束后经10分钟静脉给予首剂药物或溶媒,随后进入院前阶段以自体全血维持MAP 65 mm Hg,90分钟后进行「院内」复苏,术后经8小时静脉给予第二剂溶媒或氨甲环酸。氨甲环酸在三个测试剂量下于24、48、72小时均较溶媒显著改善神经功能缺损;脑血红蛋白含量和脑内病灶进展分析显示100 mg/kg提供最佳神经病理改善效果,并继续用于不良反应评估。未观察到脑血栓形成加重,但氨甲环酸治疗导致脑电图异常风险增加。作者认为,多发性创伤合并脑损伤后使用氨甲环酸可能通过防止病灶进展提供轻度神经保护作用,但这可能与脑电图异常模式风险增加相关;该风险可能与氨甲环酸抑制甘氨酸受体有关,在严重TBI患者中使用氨甲环酸时可能需要额外考虑。
要点
- 在大鼠穿透性TBI合并低氧血症和失血性休克模型中,氨甲环酸在24、48、72小时三个剂量下均较溶媒显著改善神经功能缺损。
- 脑血红蛋白含量和脑内病灶进展分析显示100 mg/kg为改善神经病理的最佳剂量,并用于后续不良反应评估。
- 氨甲环酸未加重脑血栓形成,但治疗导致脑电图异常风险增加。
- 作者认为氨甲环酸可能通过防止病灶进展提供轻度神经保护,但可能与脑电图异常风险增加相关。
- 该脑电图异常风险可能与氨甲环酸抑制甘氨酸受体有关,在严重TBI患者中使用时可能需要额外考虑。
适用人群与场景
- Sprague-Dawley大鼠,单侧额叶穿透性弹道样脑损伤合并低氧血症和失血性休克模型。
处置流程与药物剂量
- 脑损伤后5分钟开始30分钟呼吸窘迫和30分钟失血;失血结束后经10分钟静脉给予首剂药物或溶媒,随后进入院前阶段。
- 院前阶段按需给予自体回收全血以维持MAP 65 mm Hg;90分钟后进行「院内」复苏,给予剩余自体回收全血并提供100%氧气15分钟。
- 术后经8小时静脉给予第二剂溶媒或氨甲环酸;氨甲环酸三个剂量均改善神经功能缺损,100 mg/kg为改善神经病理的最佳剂量。
研究设计与关键结果
- 研究类型为大鼠实验;在三个测试剂量下,氨甲环酸在24、48、72小时均较溶媒显著改善神经功能缺损。
- 脑血红蛋白含量和脑内病灶进展分析显示100 mg/kg提供最佳神经病理改善效果,并继续用于不良反应评估。
- 未观察到脑血栓形成加重,但氨甲环酸治疗导致脑电图异常风险增加。
证据类型、等级与局限
- 证据类型:动物实验(大鼠模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,多发性创伤合并脑损伤后使用氨甲环酸可能通过防止病灶进展提供轻度神经保护作用,但这可能与脑电图异常模式风险增加相关。
- 作者认为,该脑电图异常风险可能与氨甲环酸抑制甘氨酸受体有关,在严重TBI患者中使用氨甲环酸时可能需要额外考虑。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Several studies have demonstrated the clinical utility of tranexamic acid (TXA) for use in trauma patients presenting with significant hemorrhage. Tranexamic acid is an antifibrinolytic that inhibits plasminogen activation, and plasmin activity has been shown to mitigate blood loss and reduce all-cause mortality in the absence of adverse vascular occlusive events. Recent clinical developments indicate TXA is safe to use in patients with concomitant traumatic brain injury (TBI); however, the prehospital effects are not well understood. Importantly, TXA has been associated with seizure activity. Therefore, this study sought to evaluate the effects of early administration of TXA on neurological recovery and electroencephalogram (EEG) abnormalities following penetrating TBI with concomitant hypoxemia and hemorrhagic shock. We hypothesized that early administration of TXA will provide hemodynamic stabilization and reduce intracerebral hemorrhage, which will result in improved neurological function. To test this hypothesis, Sprague-Dawley rats received a unilateral, frontal penetrating ballistic-like brain injury by inserting a probe into the frontal cortex of the anesthetized rat. Five minutes following brain injury, animals underwent 30 min of respiratory distress and 30 min of hemorrhage. Upon completion of the hemorrhage phase, animals received the initial dose of drug intravenously over 10 min after which the prehospital phase was initiated. During the prehospital phase, animals received autologous shed whole blood as needed to maintain a MAP of 65 mm Hg. After 90 min, "in-hospital" resuscitation was performed by administering the remaining shed whole blood providing 100% oxygen for 15 min. Upon recovery from surgery, animals were administered their second dose of vehicle or TXA intravenously over 8 h. Tranexamic acid induced an early improvement in neurologic deficit, which was statistically significant compared with vehicle at 24, 48, and 72 h at three doses tested. Analysis of cerebral hemoglobin content and intracerebral lesion progression revealed 100 mg/kg provided the optimal effects for improvement of neuropathology and was continued for determination of adverse treatment effects. We observed no exacerbation of cerebral thrombosis, but TXA treatment caused an increased risk of EEG abnormalities. These results suggest that TXA following polytrauma with concomitant brain injury may provide mild neuroprotective effects by preventing lesion progression, but this may be associated with an increased risk of abnormal EEG patterns. This risk may be associated with TXA inhibition of glycine receptors and may warrant additional considerations during the use of TXA in patients with severe TBI.
参考来源
- Bailey ZS, Yang X, Cardiff K, et al. EFFECTS OF TRANEXAMIC ACID ON NEUROPATHOLOGY, ELECTROENCEPHALOGRAPHY, AND CEREBRAL FIBRIN DEPOSITION IN A RAT MODEL OF POLYTRAUMA WITH CONCOMITANT PENETRATING TRAUMATIC BRAIN INJURY. Shock. 2023. PMID: 37267223. doi:10.1097/SHK.0000000000002154
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。